GlassScriptPhysician profile
Erin Seefeldt
NPI 1629225024
$2,984.92
in general payments reported to CMS, 2019-2025
13 companies · $1,411 in 2025
The $1,411 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.36 · 2022: $255 · 2023: $465 · 2024: $841 · 2025: $1,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,621 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52.67 · Honoraria: $25.59 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,620.55 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52.67 |
| Honoraria | $25.59 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,276.28 | 2022-2025 | Clareon, Centurion, Hydrus Microstent |
| Abbvie INC. | $1,039.51 | 2022-2025 | Xen Glaucoma Treatment System |
| Rxsight INC | $242.00 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Glaukos Corporation | $149.38 | 2024 | Ce-Marked Kxla System, Gts100_glaukos Istent Trabecular Micro-Bypass Stent System |
| Sight Sciences, INC. | $55.14 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Regeneron Healthcare Solutions, INC. | $47.56 | 2021-2024 | Eylea Hd |
| Amgen INC. | $38.46 | 2024 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $29.00 | 2024 | Xdemvy |
| Dompe US, INC. | $28.76 | 2024 | Oxervate |
| Sun Pharmaceutical Industries INC. | $22.77 | 2025 | |
| Biotissue Holdings INC. | $19.20 | 2022 | |
| New World Medical,INC. | $19.02 | 2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Clearpath |
| Bausch & Lomb Americas INC. | $17.84 | 2023 | Miebo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Seefeldt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.